Biomedical Engineering Reference
In-Depth Information
87. Bivas-Benita, M., van Meijgaarden, K. E., Franken, K. L. M. C., Junginger, H. E, Borchard, G.,
Ottenhoff, T. H. M., and Geluk, A. 2004. Pulmonary delivery of chitosan-DNA nanoparticles
enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell
epitopes of Mycobacterium tuberculosis. Vaccine 22: 1609-1615.
88. Shell, J. W. 1982. Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 26:
207-218.
89. Lehr, C. M., Bouwstra1, J. A., Schacht, E. H., and Junginger, H. E., 1992. In vitro evaluation of
mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 78: 43-48.
90. Park, K. and Robinson, J. R. 1984. Bioadhesive polymers as platforms for oral-controlled drug
delivery—Method to study bioadhesion. Int J Pharm 19: 107-127.
91. Wang, X. and D. Xu, D. 1994. Viscosity and flow properties of concentrated solutions of chito-
san with different degrees of deacetylation. Int J Biol Macromol 16: 149-152.
92. El-Samaligy, M. S., Rojanasakul, Y. R., Charlton, J. F., Weinstein, G. W., and Lim, J. K. 1996.
Ocular disposition of nanoencapsulated acyclovir and ganciclovir via intravitreal injection in
rabbit's eye. Drug Deliv 3: 93-97.
93. De Campos, A. M., Sanchez, A., and Alonso, M. J. 2001. Chitosan nanoparticles: A new vehicle
for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
Int J Pharm 224: 159-168.
94. Thacharodi, D. and Rao, K. P. 1993. Propranolol hydrochloride release behaviour of cross-
linked chitosan membranes. J Chem Technol Biotechnol 58: 177-181.
95. Thacharodi, D. and Rao, K. P. 1996. Rate-controlling biopolymer membranes as transdermal
delivery systems for nifedipine: Development and in vitro evaluations. Biomaterials 17:
1307-1311.
96. Thacharodi, D. and Rao, K. P. 1993. Release of nifedipine through cross-linked chitosan mem-
branes. Int J Pharm 96: 33-39.
97. Nakatsuka, S. and Andarady, A. L. 1992. Permeability of vitamin B-12 in chitosan membranes.
Effect of cross-linking and blending with poly(vinyl alcohol) on permeability. J Appl Polym Sci
44: 17-28.
98. Sawayanagi, Y., Nambu, N., and Nagai, T. 1982. The use of chitosan for sustained-release prep-
arations of water-soluble drugs. Chem Pharm Bull 30: 4213-4215.
99. Kim, J. H., Kim, J. Y., Lee, Y. M., and Kim, K. Y, 1992. Controlled release of riboflavin and insulin
through cross-linked poly(vinyl alcohol)/chitosan blend membrane. J Appl Polym Sci 44:
1823-1828.
100. Tojo, K. 1987. In Transdermal Controlled Systemic Medications , Y. W. Chien, ed. New York,. NY: Marcel
Dekker, p. 127.
101. Shah, V. P., Lesko L. J., and Williams, R. L. 1995. In Vitro evaluation of transdermal drug delivery.
Eur J Pharm Biopharm 41: 163-167.
Search WWH ::




Custom Search